Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|July 17, 2019
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology GroupAdam J Esbenshade, Lisa S Kahalley, Reto Baertschiger, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Haematologica|October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemiaAlan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyCarrie L Kitko, Mukta Arora, Zachariah DeFilipp, et al.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
The New England Journal of Medicine|September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseDaniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Pediatric Blood & Cancer|November 6, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPEGemma Bryan, Louise Guolla, Gabriela Inés Villanueva, et al.
Transplantation and Cellular Therapy|October 12, 2021
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research AnalysisVijaya Raj Bhatt, Tao Wang, Karen Chen, et al.
Haematologica|June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Blood Advances|April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHDZachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Pageof 10